Company / Interest Expense per Share
Myriad Genetics, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.04
FY2023
5-year range
$0.04 / $0.09
FY2019-FY2023
Trend
-11.7%
vs FY2022
Sector context
#34 of 43
Health Care
What the data says
Myriad Genetics, Inc.'s interest expense per share of $0.04 is lower than 79% of companies in the Health Care sector (FY2023). Interest Expense per Share has declined for 3 consecutive years, from $0.16 in FY2020 to $0.04 in FY2023.
Based on SEC 10-K filings.
0.04 in FY2023 with a 5-year CAGR of -3.7%.
Improved from $0.09 to $0.04 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -37.5%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 43This company $0.04 Sector average $9.80
▼
-99.6% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s interest expense per share has declined for 3 consecutive years.
- In FY2023, interest expense per share decreased 11.7% year-over-year.
- Ranks #34 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.04 | -11.7% |
| FY2022 | $0.04 | -53.4% |
| FY2021 | $0.09 | -40.8% |
| FY2020 | $0.16 | +81.8% |
| FY2019 | $0.09 | +87.0% |
| FY2018 | $0.05 | -43.1% |
| FY2017 | $0.08 | +2093.2% |
| FY2016 | $0.00 | +53.7% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026